NEWS


5
November 2015
Thursday

Meeting of committee on social policy of the State Council of Tatarstan Republic has taken place in Municipal Clinical Hospital №7 on November, 3rd.  It has been dedicated to social, economic and psychological problem of pseudorheumatism. Chairman of committee on social policy of the State Council of Tatarstan Republic S.M.Zakharova, the deputy of TR State Council, the head physician of Municipal Clinical Hospital №7 M.N.Sadykov, managing unit of nephrology and rheumatology of FSBI «Central Hospital with polyclinic» of Administrative Department of the President of the Russian Federation A.V.Gordeev, the principal of Centre of Rheumatic Diseases and Osteoporosis of Kazan R.G.Mukhina, personnel of hospital and patients took part in the meeting.

Health personnel of SAHI «Menzelinsky CRH» had read the lecture to workers of educational institutions of Menzelinsky municipal district in Menzelinsk school №1 today.  The questions of preventive maintenance of cardiovascular diseases, flu, hepatitis, tuberculosis and necessity of vaccine prevention have been taken up. About 60 listeners have visited the lecture.  

Residential grants, founded by the government of Tatarstan, are given to the physicians coming to the work from other regions.

The principal urologist of Healthcare Department of Moscow, the vice-president of the Russian society of urologists Armais A. Kamalov has visited Republican Clinical Hospital of TR Health Ministry. Armais Kamalov has seen the work of acceptance-diagnostic unit step-by-step. Principals have visited diagnostic offices, procedure, antishock and reanimation rooms. In end of visit the honored guest has familiarized with possibilities of telemedicine on the basis of Emergency Medicine Centre. The principal urologist of Moscow A.A.Kamalov and the principal urologist of Tatarstan Republic R.H.Galeev have discussed the urology pressing questions. They agreed upon further interacting and the evolution of urological service.


SUBSCRIBE FOR NEWS
All content on this site is licensed under
Creative Commons Attribution 4.0 International